28 Oct 2025
Milestone for our portfolio company @DOMAINtx !
First patients dosed in the Phase I/II trial of DT-7012, an anti-CCR8 antibody designed to boost anti-tumor immunity in solid tumors.
#Immunotherapy #Biotech #Innovation
👉 admarebio.com/en/news-detail…
2
3
237
8 Jul 2025
Check out the latest episode on Base to Base biotech #podcast with @CarinaCarlaKern, @DOMAINtx & @SandboxAQ deeptechdigest.com/biotech/b… #ageing #longevity
2
3
166
Please share @cool7TMs @GpcReid @zenbrainest @GPCRzoominar @GpcrL @AdhesionGPCR @StuartMaudsley @yaminaberchiche @DOMAINtx @AntiverseHQ @mike_feigin #gpcr #drgpcr
1
1
4
487
We’re 2 months away from the registration deadline for the GPCR Retreat. Have you registered yet? 😱 Are you excited about this conference? 😀 Remember spots are limited!
👉Visit bit.ly/3E4HTCx and check out all the information related to the 22nd edition
#gpcrretreat
2
624
18 Jul 2023
@DOMAINtx announces @EPOorg decision to grant a composition of matter #patent in > 15 European countries for its proprietary EP4 receptor antagonist program, including the candidate DT-9081, solidifying company's position as a leading #innovator in the field of #immunooncology
1
2
3
804
6 Jul 2023
👏Félicitations à @NeuvilleP et à l'équipe de @DOMAINtx, une entreprise du portefeuille adMare, pour la désignation la semaine dernière d'un nouveau médicament candidat, DT-7012.
Pour en savoir plus : domaintherapeutics.com/domai…
2
154
6 Jul 2023
#ICYMI
👏Congratulations to @NeuvilleP and the team at @DOMAINtx, an adMare Portfolio company, for their announcement last week of the nomination of a novel drug candidate, DT-7012.
Read more: domaintherapeutics.com/domai…
3
178
5 Jul 2023
Start of the 2nd session of FICS 2023 with a talk by Christelle Doebelin from @DOMAINtx about GPCR modulators against Parkinson's disease. @unistra @AlsaceScf @reseauSCF
1
6
363
4 Jul 2023
@DOMAINtx #ImmunotherapyMonth saw some major milestones. Our #pressday spotlighted our position as the "#GPCR company" in #immunooncology, unlocking the potential of GPCRs VS cancer. Nominations of DT-9045 & DT-7012 further confirmed our commitment to innovative #cancertreatments
1
107
30 Jun 2023
𝐂𝐎𝐍𝐅𝐄𝐑𝐄𝐍𝐂𝐄 𝐃𝐄 𝐏𝐑𝐄𝐒𝐒𝐄 - Invitée par @DOMAINtx, Alicia a pu assiter à la présentation de leurs activités et à l'annonce de l'identification d'un nouveau médicament-candidat. 💊
Elle a également visité leurs #laboratoires de #chimie et de #biologie. 🧪
#presse
1
2
96
29 Jun 2023
#LSBCMember News: @DOMAINtx Announces Nomination of Best-in-Class Ccr8 Antibody Candidate, Dt-7012, Further Strengthening its Unique Portfolio of Gpcr-Targeting Immunotherapies. Read more: ow.ly/kSyR50P0N78
1
198
13 Jun 2023
👏 Félicitations à @ThryvTrx et @DOMAINtx, deux entreprises du portefeuille adMare, pour leurs formidables annonces de la semaine dernière !
Pour en savoir plus sur ces annonces, visitez ➡ admarebio.com/fr/actualites
2
1
2
227
13 Jun 2023
#ICYMI
👏 Congratulations to @ThryvTrx and @DOMAINtx, two adMare portfolio companies, for their exciting announcements last week!
To learn more about these announcements, please visit ➡
admarebio.com/en/news
2
264
3 May 2023
Don't miss a unique opportunity to meet our CEO @NeuvilleP at #LSXworld Congress 2023, London, May 3-4 & learn about @DOMAINtx #GPCR-based therapies & #precision research to unlock new possibilities in #cancer
#drugdevelopment #partnering @LSXLeaders
2
135
28 Apr 2023
Happy #GOLDENWEEK to our friends & #partners in #Japan!
A special thought to @Ono_pharma_PR, thank you for your recent visit @DOMAINtx allowing to deepen our #collaboration efforts with ONO Pharma & @Michel_Bouvier to develop a #GPCR-based solution for #patients #metabolicdisease
2
139
21 Apr 2023
For the first time, the French Industrial Chemistry Symposium FICS travels in @regiongrandest to meet the young generation (MSc to postdoc) and offer them scientific presentations and round-tables by chemists working in local companies @novalix_pharma @Roche @SopremaFR @DOMAINtx
1
5
7
1,193
20 Apr 2023
🧬Nous avons participé à la 13e conférence annuelle @BioNJ_Org avec les entreprises québécoises de Sciences de la vie @DOMAINtx, @StarpaxBiopharm, @_Pharmascience_, @feldan_com qui ont présenté leur travail innovant dans l'industrie. De belles opportunités de collaboration !🚀
1
2
151
20 Apr 2023
🧬We had a great time at the 13th Annual @BioNJ_Org Conference with Québec-based #LifeSciences companies @DOMAINtx, @StarpaxBiopharm, @_Pharmascience_, @feldan_com showcasing their innovative work in the industry. Exciting networking and collaboration opportunities! 🚀
1
3
7
460
17 Apr 2023
Check out @DOMAINtx 3 posters @AACR 2023
Our experts will present therapeutic perspectives of #GPCR targeting proprietary assets in #oncology & #immunooncology
April 17 / 1:30-5:00 PM / Poster section 23
April 18 / 1:30-5:00 PM / Poster section 16
#cancertreatment #Immunotherapy
1
127
Did you know you can join @DrGPCR Symposium “Recent Advances in Understanding Challenging GPCRs” with your FREE site membership? Dig into recent data about the most challenging GPCRs
@DOMAINtx @GraetzLukas @brendanpwilkins
🗓️March 24 ➡️bit.ly/3n7RfrU
#gpcr #drgpcr
3
6
864